BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12516096)

  • 1. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.
    de Nooij-van Dalen AG; van Dongen GA; Smeets SJ; Nieuwenhuis EJ; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 2003 Mar; 103(6):768-74. PubMed ID: 12516096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion.
    Brakenhoff RH; Gerretsen M; Knippels EM; van Dijk M; van Essen H; Weghuis DO; Sinke RJ; Snow GB; van Dongen GA
    J Cell Biol; 1995 Jun; 129(6):1677-89. PubMed ID: 7790363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells.
    Eshel R; Zanin A; Kapon D; Sagi-Assif O; Brakenhoff R; van Dongen G; Witz IP
    Int J Cancer; 2002 Apr; 98(6):803-10. PubMed ID: 11948455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LY-6K gene: a novel molecular marker for human breast cancer.
    Lee JW; Lee YS; Yoo KH; Lee KH; Park K; Ahn T; Ko C; Park JH
    Oncol Rep; 2006 Dec; 16(6):1211-4. PubMed ID: 17089039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction.
    Nieuwenhuis EJ; Leemans CR; Kummer JA; Denkers F; Snow GB; Brakenhoff RH
    Lab Invest; 2003 Aug; 83(8):1233-40. PubMed ID: 12920252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
    Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
    Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gain of novel tissue specificity in the human Ly-6 gene E48.
    Brakenhoff RH; van Dijk M; Rood-Knippels EM; Snow GB
    J Immunol; 1997 Nov; 159(10):4879-86. PubMed ID: 9366413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of the murine Ly-6A/E antigen homolog of human squamous cell carcinoma antigen E48 during malignant transformation and tumor progression of squamous cell carcinoma line Pam 212.
    Kato T; Dong G; Loukinova E; Chen Z; Van Waes C
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):408-11. PubMed ID: 9782003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.
    Eshel R; Zanin A; Sagi-Assif O; Meshel T; Smorodinsky NI; Dwir O; Alon R; Brakenhoff R; van Dongen G; Witz IP
    J Biol Chem; 2000 Apr; 275(17):12833-40. PubMed ID: 10777581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.
    Bahrenberg G; Brauers A; Joost HG; Jakse G
    Biochem Biophys Res Commun; 2000 Sep; 275(3):783-8. PubMed ID: 10973799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
    Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
    Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.
    Brakenhoff RH; van Gog FB; Looney JE; van Walsum M; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1995 Mar; 40(3):191-200. PubMed ID: 7728778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic effect of LY-6K gene in breast cancer cells.
    Choi SH; Kong HK; Park SY; Park JH
    Int J Oncol; 2009 Sep; 35(3):601-7. PubMed ID: 19639180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer.
    van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB
    Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins.
    Witz IP
    J Cell Biochem Suppl; 2000; 34():61-6. PubMed ID: 10762016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRAME expression in head and neck cancer correlates with markers of poor prognosis and might help in selecting candidates for retinoid chemoprevention in pre-malignant lesions.
    Szczepanski MJ; DeLeo AB; Ɓuczak M; Molinska-Glura M; Misiak J; Szarzynska B; Dworacki G; Zagor M; Rozwadowska N; Kurpisz M; Krzeski A; Kruk-Zagajewska A; Kopec T; Banaszewski J; Whiteside TL
    Oral Oncol; 2013 Feb; 49(2):144-51. PubMed ID: 22944049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma.
    van Hal NL; van Dongen GA; Stigter-van Walsum M; Snow GB; Brakenhoff RH
    Int J Cancer; 1999 Sep; 82(6):837-45. PubMed ID: 10446451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.
    Hirata S; Katoh O; Oguri T; Watanabe H; Yajin K
    Jpn J Cancer Res; 2000 Jan; 91(1):84-90. PubMed ID: 10744048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.